Research Article
The Relationships between Leptin, Genotype, and Chinese Medicine Body Constitution for Obesity
Table 3
Comparisons of demographic features and comorbidities with three traditional Chinese medicine body constitutions (TCMBC).
| | Parameters | Yang deficiency (YangDC) | Yin deficiency (YinDC) | Phlegm-stasis (PSC) | | (+) n = 29 | (−) n = 21 | | (+) n = 33 | (−) n = 17 | | (+) n = 29 | (−) n = 21 | |
| | Demographic features | | Gender | | | 0.003 | | | 0.002 | | | 0.097 | | Female | 26 (89.7%) | 11 (52.4%) | | 29 (87.9%) | 8 (47.1%) | | 24 (82.8%) | 13 (61.9%) | | | Male | 3 (10.3%) | 10 (47.6%) | | 4 (12.1%) | 9 (52.9%) | | 5 (17.2%) | 8 (38.1%) | | | Age (years), mean (SD) | 37.7 (10.3) | 36.0 (8.7) | 0.54 | 37.9 (9.8) | 35.2 (9.2) | 0.34 | 37.1 (10.3) | 36.8 (8.8) | 0.89 | | BMI, mean (SD) | 30.8 (3.2) | 31.6 (3.2) | 0.42 | 31.1 (3.1) | 31.2 (3.5) | 0.93 | 30.8 (3.2) | 31.6 (3.3) | 0.43 | | Waist-hip ratio (WHR), mean (SD) | 0.9 (0.1) | 0.9 (0.0) | 0.20 | 0.9 (0.1) | 0.9 (0.0) | 0.19 | 0.9(0.1) | 0.9 (0.0) | 0.56 | | Waist-height ratio (WheR), mean (SD) | 0.6 (0.1) | 0.6 (0.0) | 0.67 | 0.6 (0.0) | 0.6 (0.0) | 0.35 | 0.6 (0.1) | 0.6 (0.0) | 0.24 | | Appetite | | | 0.10 | | | 0.57 | | | 0.35 | | Poor | 2 (6.9%) | 0 (0.0%) | | 2 (6.1%) | 0 (0.0%) | | 2 (6.9%) | 0 (0.0%) | | | Fair | 26 (89.7%) | 17 (81.0%) | | 28 (84.8%) | 15 (88.2%) | | 25 (86.2%) | 18 (85.7%) | | | Good | 1 (3.4%) | 4 (19.0%) | | 3 (9.1%) | 2 (11.8%) | | 2 (6.9%) | 3 (14.3%) | | | Food preference | | | | | | | | | | | Icy food | 9 (31.0%) | 3 (14.3%) | 0.17 | 9 (27.3%) | 3 (17.6%) | 0.45 | 10 (34.5%) | 2 (9.5%) | 0.041 | | Deep-fried food | 8 (27.6%) | 2 (9.5%) | 0.12 | 8 (24.2%) | 2 (11.8%) | 0.30 | 9 (31.0%) | 1 (4.8%) | 0.022 | | Smoking | 2 (6.9%) | 1 (4.8%) | 0.75 | 2 (6.1%) | 1 (5.9%) | 0.98 | 2 (6.9%) | 1 (4.8%) | 0.75 | | Alcohol consumption | 12 (41.4%) | 13 (61.9%) | 0.15 | 13 (39.4%) | 12 (70.6%) | 0.037 | 13 (44.8%) | 12 (57.1%) | 0.39 | | Exercise ≥30 mins/week | 23 (79.3%) | 17 (81.0%) | 0.89 | 27 (81.8%) | 13 (76.5%) | 0.65 | 24 (82.8%) | 16 (76.2%) | 0.57 | | Comorbidities | | | | | | | | | | | Hyperlipidemia | 1 (3.4%) | 1 (4.8%) | 0.82 | 2 (6.1%) | 0 (0.0%) | 0.30 | 1 (3.4%) | 1 (4.8%) | 0.82 | | Hypertension | 5 (17.2%) | 3 (14.3%) | 0.78 | 5 (15.2%) | 3 (17.6%) | 0.82 | 5 (17.2%) | 3 (14.3%) | 0.78 | | Diabetes mellitus | 0 (0.0%) | 2 (9.5%) | 0.090 | 0 (0.0%) | 2 (11.8%) | 0.044 | 0 (0.0%) | 2 (9.5%) | 0.090 | | Stroke | 0 | 0 | 1.00 | 0 | 0 | 1.00 | 0 | 0 | 1.00 | | Myocardial infarction | 0 | 0 | 1.00 | 0 | 0 | 1.00 | 0 | 0 | 1.00 | | Allergic rhinitis | 6 (20.7%) | 4 (19.0%) | 0.89 | 8 (24.2%) | 2 (11.8%) | 0.30 | 8 (27.6%) | 2 (9.5%) | 0.12 | | Polycystic ovarian syndrome | 1 (3.4%) | 0 (0.0%) | 0.39 | 0 | 0 | 1.00 | 0 (0.0%) | 1 (4.8%) | 0.24 |
|
|
